指南与共识膀胱癌与上尿路尿路上皮癌

根治性膀胱切除术后抗菌预防指南的国家依从性

National Adherence to Guidelines for Antimicrobial Prophylaxis for Patients Undergoing Radical Cystectomy.
指南 / 共识 · J Urol · 2022-11-16

利用Premier医疗数据库分析2015至2020年间6708例因膀胱癌行根治性膀胱切除加回肠 conduit 的患者,仅28%按2019 AUA指南进行抗菌预防。指南依从性预防与尿路感染、肾盂肾炎、细菌感染和肺炎风险降低相关,非指南预防与感染事件风险升高相关(OR 1.27)。

要点

  • 仅28%(1843/6708)患者接受符合AUA指南的抗菌预防,37%延长预防超过术后第1天。
  • 指南依从性预防组尿路感染21% vs 非依从组24%(P = .04),肾盂肾炎5.1% vs 7.7%(P < .001)。
  • 非指南抗菌预防与感染事件风险升高相关(OR 1.27 [1.12, 1.43],P < .001),机器人入路与风险降低相关(OR 0.82 [0.73, 0.92],P < .001)。

核心结论

  • 73%的患者在接受根治性膀胱切除加 conduit 时未能接受基于指南的抗菌预防,主要原因是延长了抗生素使用时间。
  • 尽管指南依从性预防的抗生素使用时间更短,但与感染并发症风险降低25%相关。
  • 作者认为这些数据支持当前AUA指南,并提示需要开展外展活动以提高指南依从性。

研究设计与样本

  • 回顾性查询Premier医疗数据库,纳入2015至2020年间因膀胱癌行膀胱切除加回肠 conduit 的所有患者。
  • 根据收费代码确定抗生素使用及持续时间,并按2019 AUA指南分为基于指南或不基于指南。
  • 通过 logistic 混合效应回归模型评估与感染并发症的关联。

主要发现

  • 共6708例患者,仅28%(1843/6708)接受了符合AUA指南的预防;1.8%(121/6708)接受了抗真菌药;37%(2482/6708)预防时间延长至术后第1天以后。
  • 指南依从组与非依从组相比:尿路感染21% vs 24%(P = .04);肾盂肾炎5.1% vs 7.7%(P < .001);细菌感染24% vs 27%(P = .03);肺炎12% vs 17%(P < .001)。
  • 指南依从组与非依从组艰难梭菌感染无统计学显著差异(3.2% vs 3.7%,P = .32)。
  • 多变量 logistic 回归调整年龄、种族、保险及医院和提供者特征后,非指南抗生素预防与感染事件风险升高相关(OR 1.27 [1.12, 1.43],P < .001),机器人入路与感染事件风险降低相关(OR 0.82 [0.73, 0.92],P < .001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文指出可能存在残余混杂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The sentinel reference for antibiotic prophylaxis for radical cystectomy with ileal conduit in the AUA Guidelines reports data from 2003-2013 and has not been updated in the interim. Here, we assess adherence to antibiotic prophylaxis guidelines among patients undergoing radical cystectomy with ileal conduit for bladder cancer using a large national database. As a secondary objective, we assess the association between antimicrobial use and postoperative infection during the index admission following cystectomy. MATERIALS AND METHODS: The Premier Healthcare Database was queried for all patients undergoing cystectomy with ileal conduit with diagnosis of bladder cancer between 2015 and 2020. Antibiotics used and the duration of use was determined by charge codes and grouped as guidelines-based or not according to 2019 AUA Guidelines. Association with infectious complications was assessed by logistic mixed effects regression models. RESULTS: Among 6,708 patients undergoing cystectomy with ileal conduit, only 28% (1,843/6,708) were given prophylaxis according to AUA guidelines; 1.8% (121/6,708) of patients received an antifungal and 37% (2,482/6,708) received extended duration prophylaxis beyond postoperative day 1. Patients who received guidelines-based prophylaxis were less likely to be diagnosed with a urinary tract infection (21% vs 24%, P = .04), pyelonephritis (5.1% vs 7.7%, P < .001), bacterial infection (24% vs 27%, P = .03), or pneumonia (12% vs 17%, P < .001). There was no statistically significant difference in clostridium difficile infection between guidelines-based and nonguidelines-based prophylaxis (3.2% vs 3.7%, P = .32). In a multivariable logistic regression adjusting for age, race, insurance, and hospital and provider characteristics, nonguideline antibiotic prophylaxis (OR 1.27 [1.12, 1.43], P < .001) was associated with an increased odds of infectious events, whereas a robotic approach (OR 0.82 [0.73, 0.92], P < .001) was associated with lower odds. CONCLUSIONS: Seventy-three percent of patients fail to receive guideline-based antibiotic prophylaxis when undergoing radical cystectomy with conduit, which was largely driven by extended duration antibiotic use. Despite the shorter duration of antibiotics, we found that guideline-based prophylaxis was associated with a 25% decrease in the odds of infectious complications. While residual confounding is possible, these data support current AUA guidelines and suggest a need for outreach to improve guideline adherence.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Prunty M, Rhodes S, Rivero MJ, et al. National Adherence to Guidelines for Antimicrobial Prophylaxis for Patients Undergoing Radical Cystectomy. J Urol. 2022. PMID: 36383758. doi:10.1097/JU.0000000000003069

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。